MedTrace Logo

Megaprosthetic Implants the Next Generation (MING)

NCT03780036 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-12-19

No results posted yet for this study

Summary

This is an interventional randomized controlled trial that will compare patients who underwent segmental hip replacement using mega-implants with either porous collar or porous collar with HA. Patient recruitment will continue for 18 months. Parameters to be investigated are radiographic measures of bone incorporation into the implants, as well as patient functional outcomes. Clinical follow-up will last for 24 months for each patient.

Conditions

  • Bone Neoplasm of Hip (Diagnosis)

Interventions

DEVICE

Megaprosthetic Implants the Next Generation (MING)

Use of either porous of porous+hydroxyapathite collars.

Sponsors & Collaborators

  • Adler Ortho, iEthos Medical Ltd

    collaborator UNKNOWN

  • Tel-Aviv Sourasky Medical Center

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2022-08-01
Completion
2022-08-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03780036 on ClinicalTrials.gov